Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase-9

Journal of Cellular Physiology

Volumn 227, Issue 3, 2012, Pages 1052-1061

  Mohammad, Ghulam ^a   Kowluru, Renu A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; SMALL INTERFERING RNA;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CAPILLARY; CELL STRUCTURE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; ONCOGENE H RAS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RETINA BLOOD VESSEL; STRUCTURE ANALYSIS;

ADULT; AGED; ANIMALS; APOPTOSIS; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROCIRCULATION; MIDDLE AGED;

EID: 84155174644     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22822     Document Type: Article

References (48)

1. Arch JR. 2002. Lessons in obesity from transgenic animals. J Endocrinol Invest 25: 867-875.
2. Bhatt LK, Addepalli V. 2010. Attenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic rats. Am J Transl Res 12: 181-189.
3. Chattopadhyay S, Shubayev VI. 2009. MMP-9 controls Schwann cell proliferation and phenotypic remodeling via IGF-1 and ErbB receptor-mediated activation of MEK/ERK pathway. Glia 57: 1316-1325.
4. Cheng TH, Shih NL, Chen SY, Loh SH, Cheng PY, Tsai CS, Liu SH, Wang DL, Chen JJ. 2001. Reactive oxygen species mediate cyclic strain-induced endothelin-1 gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in endothelial cells. J Mol Cell Cardiol 42: 1802-1814.
5. Cox AD, Der CJ. 2002. Ras family signaling: Therapeutic targeting. Cancer Biol Ther 1: 599-606.
6. Das A, McLamore A, Song W, McGuire PG. 1999. Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor. Arch Ophthalmol 117: 498-503.
7. Deryugina EI, Quigley JP. 2010. Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functions. Biochim Biophys Acta 1803: 103-120.
8. Du Y, Tang J, Li G, Berti-Mattera L, Lee CA, Bartkowski D, Gale D, Monahan J, Niesman MR, Alton G, Kern TS. 2010. Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function. Invest Ophthalmol Vis Sci 51: 2158-2164.
9. Frank RN. 2004. Diabetic retinopathy. N Engl J Med 350: 48-58.
10. Geraldes P, King GL. 2010. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 106: 1319-1331.
11. Giebel SJ, Menicucci G, McGuire PG, Das A. 2005. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest 85: 567-607.
12. Huang Q, Sheibani N. 2008. High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs. Am J Physiol Cell Physiol 295: C1647-C1657.
13. Kanwar M, Kowluru RA. 2008. Diabetes regulates small molecular weight G-protein, H-Ras, in the microvasculature of the retina: Implication in the development of retinopathy. Microvasc Res 76: 189-193.
14. Kanwar M, Kowluru RA. 2009. Role of glyceraldehyde 3-phosphate dehydrogenase in the development and progression of diabetic retinopathy. Diabetes 58: 227-234.
15. Karasarides M, Dee K, Schulman D, Wolfman A, Weyman CM. 2006. Active Ras-induced effects on skeletal myoblast differentiation and apoptosis are independent of constitutive PI3-kinase activity. Cell Biol Int 30: 308-318.
16. Kern TS, Tang J, Mizutani M, Kowluru R, Nagraj R, Lorenzi M. 2000. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: Comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 41: 3972-3978.
17. Khan ZA, Chakrabarti S. 2007. Cellular signaling and potential new treatment targets in diabetic retinopathy. Exp Diabetes Res 2007: 31867.
18. Klein C, Creach K, Irintcheva V, Hughes KJ, Blackwell PL, Corbett JA, Baldassare JJ. 2006. Zinc induces ERK-dependent cell death through a specific Ras isoform. Apoptosis 11: 1933-11944.
19. Kowluru RA. 2010. Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras. Invest Ophthalmol Vis Sci 51: 4320-4326.
20. Kowluru RA, Kanwar M. 2009a. Oxidative stress and the development of diabetic retinopathy: Contributory role of matrix metalloproteinase-2. Free Radic Biol Med 46: 1677-1685.
21. Kowluru RA, Kanwar M. 2009b. Translocation of H-Ras and its implications in the development of diabetic retinopathy. Biochem Biophys Res Commun 387: 461-466.
22. Kowluru V, Kowluru RA. 2007. Increased oxidative stress in diabetes regulates activation of a small molecular weight G-protein, H-Ras, in the retina. Mol Vis 13: 602-610.
23. Kowluru RA, Odenbach S. 2004. Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol 88: 1343-1347.
24. Kowluru RA, Jirousek MR, Stramm LE, Farid NA, Engerman RL, Kern TS. 1998. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. V. Relationship between protein kinase C and ATPases. Diabetes 47: 464-469.
25. Kowluru RA, Tang J, Kern TS. 2001. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50: 1938-1942.
26. Kowluru RA, Koppolu P, Chakrabarti S, Chen S. 2003. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Res 37: 1169-1180.
27. Kowluru RA, Kowluru A, Chakrabarti S, Khan Z. 2004. Potential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic rats. Diabetes 53: 775-783.
28. Kowluru RA, Kowluru A, Kanwar M. 2007. Small molecular weight G-protein, H-Ras, and retinal endothelial cell apoptosis in diabetes. Mol Cell Biochem 296: 69-76.
29. Lee KW, K N, Heo YS, Rogozin EA, Pugliese A, Hwang MK, Bowden GT, Bode AM, Lee HJ, Dong Z. 2008. Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res 68: 946-955.
30. Li W, Li H, Bocking AD, Challis JR. 2010. Tumor necrosis factor stimulates matrix metalloproteinase 9 secretion from cultured human chorionic trophoblast cells through TNF receptor 1 signaling to IKBKB-NFKB and MAPK1/3 pathway. Biol Reprod 83: 481-487.
31. Malemud CJ. 2006. Matrix metalloproteinases (MMPs) in health and disease: An overview. Front Biosci 11: 1696-1701.
32. Miyamoto N, de Kozak Y, Jeanny JC, Glotin A, Mascarelli F, Massin P, BenEzra D, Behar-Cohen F. 2007. Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: Potential implication in the pathogenesis of diabetic retinopathy. Diabetologia 50: 461-470.
33. Mizutani M, Kern TS, Lorenzi M. 1996. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97: 2883-2890.
34. Mohammad G, Kowluru RA. 2010. Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction. Lab Invest 90: 1365-1372.
35. Nilsson MB, Zage PE, Zeng L, Xu L, Cascone T, Wu HK, Saigal B, Zweidler-McKay PA, Heymach JV. 2010. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: Implications for antiangiogenic mechanisms of multikinase inhibitors. Oncogene 29: 2938-2949.
36. Omerovic J, Prior IA. 2009. Compartmentalized signalling: Ras proteins and signalling nanoclusters. FEBS J 276: 1817-1825.
37. Rayappa S, Kowluru RA. 2008. Role of Raf-1 kinase in diabetes-induced accelerated apoptosis of retinal capillary cells. Int J Biomed Sci 4: 20-28.
38. Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M. 2002. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51: 2241-2248.
39. Schäfers M, Schober O, Hermann S. 2010. Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques. J Nucl Med 51: 663-666.
40. Schubbert S, Bollag G, Shannon K. 2007. Deregulated Ras signaling in developmental disorders: New tricks for an old dog. Curr Opin Genet Dev 17: 15-22.
41. Serban D, Leng J, Cheresh D. 2008. H-ras regulates angiogenesis and vascular permeability by activation of distinct downstream effectors. Circ Res 102: 1350-1358.
42. Stitt AW. 2003. The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp Mol Pathol 75: 95-108.
43. Stitt AW. 2010. AGEs and diabetic retinopathy. Invest Ophthalmol Vis Sci 51: 4867-4874.
44. Thrailkill KM, Clay Bunn R, Fowlkes JL. 2009. Matrix metalloproteinases: Their potential role in the pathogenesis of diabetic nephropathy. Endocrine 35: 1-10.
45. Tyagi SC, Rodriguez WPA, Roberts AM, Falcone JC, Passmore JC, Fleming JT, Joshua IG. 2005. Hyperhomocysteinemic diabetic cardiomyopathy: Oxidative stress, remodeling, and endothelial-myocyte uncoupling. J Cardiovasc Pharmacol Ther 10: 1-10.
46. Zheng L, Szabo C, Kern TS. 2004. Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 53: 2960-2967.
47. Zhong Q, Kowluru RA. 2010. Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon. J Cell Biochem 110: 1306-1313.
48. Zhuang S, Schnellmann RG. 2006. A death-promoting role for extracellular signal-regulated kinase. J Pharmacol Exp Ther 319: 991-997.